Literature DB >> 21187088

Anandamide inhibits oxidative phosphorylation in isolated liver mitochondria.

Patrizia Zaccagnino1, Angela Corcelli, Maristella Baronio, Michele Lorusso.   

Abstract

A study on the effect of anandamide (AEA) in energy coupling of rat liver mitochondria is presented. Micromolar concentrations of AEA, while almost ineffective on substrate supported oxygen consumption rate and on uncoupler stimulated respiration, strongly inhibited the respiratory state III. AEA did not change the rate and the extent of substrate generated membrane potential, but markedly delayed rebuilding by respiration of the potential collapsed by ADP addition. Overall, these data suggest that anandamide inhibits the oxidative phosphorylation process. Direct measurement of the F(o)F(1) ATP synthase activity showed that the oligomycin sensitive ATP synthesis was inhibited by AEA, (IC(50), 2.5 μM), while the ATP hydrolase activity was unaffected. Consistently, AEA did not change the membrane potential generated by ATP hydrolysis.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21187088     DOI: 10.1016/j.febslet.2010.12.032

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria.

Authors:  Patrizia Zaccagnino; Susanna D'Oria; Luigi Luciano Romano; Almerinda Di Venere; Anna Maria Sardanelli; Michele Lorusso
Journal:  J Bioenerg Biomembr       Date:  2012-03-22       Impact factor: 2.945

2.  Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.

Authors:  Guillermo B Silva; Douglas K Atchison; Luis I Juncos; Néstor H García
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-05

Review 3.  Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease.

Authors:  Virna Margarita Martín Giménez; Sandra Edith Noriega; Diego Enrique Kassuha; Lucía Beatriz Fuentes; Walter Manucha
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-05-16

Review 4.  The endocannabinoid system in normal and pathological brain ageing.

Authors:  Andras Bilkei-Gorzo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 5.  Biophysical characterization of melanoma cell phenotype markers during metastatic progression.

Authors:  Anna Sobiepanek; Alessio Paone; Francesca Cutruzzolà; Tomasz Kobiela
Journal:  Eur Biophys J       Date:  2021-03-17       Impact factor: 1.733

6.  Cannabinoid-1 receptor regulates mitochondrial dynamics and function in renal proximal tubular cells.

Authors:  Adi Drori; Anna Permyakova; Rivka Hadar; Shiran Udi; Alina Nemirovski; Joseph Tam
Journal:  Diabetes Obes Metab       Date:  2018-09-10       Impact factor: 6.577

Review 7.  Endocannabinoids in neuroendopsychology: multiphasic control of mitochondrial function.

Authors:  Alistair Nunn; Geoffrey Guy; Jimmy D Bell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

8.  Mitochondrial complex I inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death.

Authors:  Roberta Palorini; Tiziana Simonetto; Claudia Cirulli; Ferdinando Chiaradonna
Journal:  Int J Cell Biol       Date:  2013-04-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.